Search results
EXCLUSIVE: Local teen among first to receive groundbreaking diabetes treatment
WRBL Columbus via Yahoo News· 20 hours agoCOLUMBUS, Ga. (WRBL) — One of the first patients in the world to be treated by a new drug is getting...
Epigenetic Markers May Predict Kidney Failure Risk in T1D
Medscape· 2 days agoMedscape Medical NewsEpigenetic Markers May Predict Kidney Failure Risk in T1DMarilynn Larkin May...
JDRF-Authored Paper Shows Pathway to Accelerate Disease-Modifying Therapies for People with Type 1 ...
CBS 47 Fresno· 4 days agoThe paper, written by JDRF Vice President of Research Esther Latres, Ph.D., and co-authored by JDRF staff and other leaders in the field, reviewed...
Three schools unite at Seabreeze Park to combat type one diabetes
13WHAM Rochester· 5 days agoThe Byron-Bergen, Elba, and Oakfield-Alabama learning communities are teaming up to “stick it to ...
Experts demand obesity action to cure sick note Britain after diabetes surge
Daily Express· 3 days agoExperts are demanding a “tough love” crackdown on obesity to cure sick note Britain after a report...
Managing Diabetes: Proven Strategies and Treatment Options
Digital Journal· 7 days agoOther interested individuals can view the full article at https://valleant.com/2023/12/12/how-to-cure-diabetes/ . The article includes several interesting ...
Is CRISPR Therapeutics a Millionaire Maker?
Motley Fool via Yahoo Finance· 2 days agoOf particular interest is the CTX211 program for type 1 diabetes, which is currently in phase 1 trials. CTX211 aims ...
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity - Vertex...
Benzinga· 15 hours agoVertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes. Where Is Vertex ...
Is CRISPR Therapeutics Stock a Buy?
Motley Fool via Yahoo Finance· 7 days agoThough CRISPR Therapeutics' work in that indication is still in the early stages, the company has five non-Casgevy candidates in clinical trials,...
Moderna’s long Covid plan
Politico· 17 hours agoHow so? Women led the way. In January 2020, about 4,900 in the 12-25 age range were getting the drugs, which reduce appetite by mimicking the GLP-1...
